**
Overview
Hypertrophic cardiomyopathy (HCM) is a complex and potentially life-threatening heart condition that affects approximately 1 in 500 people worldwide. It is the most common cause of sudden cardiac death in young athletes and is often inherited in an autosomal dominant pattern. HCM is characterized by the thickening of the heart muscle, which can lead to abnormal heart function, including reduced cardiac output, arrhythmias, and increased risk of heart failure.
The symptoms of HCM can vary widely, ranging from asymptomatic to severe shortness of breath, chest pain, and fainting spells. In some cases, HCM may not cause any noticeable symptoms until it has progressed to a more advanced stage. The condition can be diagnosed through a combination of physical examination, electrocardiogram (ECG), echocardiogram, and cardiac magnetic resonance imaging (MRI).
History/Background
The first reported case of HCM dates back to 1900, when a British physician named James Parkinson described a patient with a thickened heart muscle. However, it wasn't until the 1960s that the condition was formally recognized as a distinct clinical entity. Since then, significant advances have been made in understanding the genetic and molecular mechanisms underlying HCM, as well as the development of effective treatments and management strategies.
Key Information
HCM is caused by mutations in genes that code for proteins involved in the regulation of cardiac muscle contraction and relaxation. The most common genes associated with HCM are MYBPC3, MYH7, and TNNT2. The condition can be inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is sufficient to cause the condition.
The diagnosis of HCM typically involves a combination of clinical evaluation, ECG, echocardiogram, and cardiac MRI. The American Heart Association recommends that individuals with a family history of HCM undergo regular screening, including ECG and echocardiogram, starting at age 12.
Significance
HCM is a significant public health concern due to its high prevalence and potential for life-threatening complications. According to the American Heart Association, HCM is responsible for approximately 25% of sudden cardiac deaths in young athletes. Early detection and management of HCM can significantly improve outcomes and reduce the risk of complications.
INFOBOX:
- Name: Hypertrophic Cardiomyopathy (HCM)
- Type: Genetic heart condition
- Date: 1900 (first reported case)
- Location: Worldwide
- Known For: Most common cause of sudden cardiac death in young athletes
TAGS:
Genetic heart conditions, hypertrophic cardiomyopathy, sudden cardiac death, cardiac muscle thickening, heart failure, arrhythmias, cardiac MRI, echocardiogram, electrocardiogram, genetic testing.
Important Note: If you or a family member has been diagnosed with HCM, it is essential to seek regular medical care and follow-up appointments with a cardiologist. Early detection and management of HCM can significantly improve outcomes and reduce the risk of complications.
